Poly(lactic-co-glycolic acid) nanomaterial-based treatment options for pain management: A review

17Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neuropathic pain is one of the most intense types of chronic pain; it constitutes a pervasive complaint throughout the public health system. With few effective treatments, it remains a significant challenge. Commercially available drugs for neuropathic pain are still limited and have disappointing efficacy. Therefore, chronic neuropathic pain imposes a tremendous burden on patients' quality of life. Recently, the introduction and application of nanotechnology in multiple fields has accelerated the development of new drugs. This review highlights the application of poly(lactic-co-glycolic acid) nanomaterial-based vehicles for drug delivery and how they improve the therapeutic outcomes for neuropathic pain treatment. Finally, future developments for pain research and effective management are presented.

Cite

CITATION STYLE

APA

Phm, T. L., & Kim, D. W. (2020, August 1). Poly(lactic-co-glycolic acid) nanomaterial-based treatment options for pain management: A review. Nanomedicine. Future Medicine Ltd. https://doi.org/10.2217/nnm-2020-0114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free